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Open reading frame (ORF) 3 of the genome of lactate dehydrogenase-elevating virus (LDV), strain P, was cloned into the
plasmid pcDNAI/Amp and in vitro transcribed and translated. Translation of ORF 3 yielded a soluble protein of the expected
size (about 21 kDa). When synthesized in the presence of endoplasmic reticulum (ER) membranes the resulting glycoprotein
of about 36 kDa became associated with the membranes. However, disruption of the ER vesicles by incubation in carbonate
buffer, pH 11.5, resulted in the release of the protein from the membranes. Hydrophobic moment analysis of the ORF 3
protein indicated the absence of any potential transmembrane segments, except for a N-terminal signal peptide, but no
cleavage of the signal peptide was observed during membrane-associated in vitro synthesis. The ORF 3 protein elicited a
strong antibody response in infected mice. The antibodies from infected mice as well as a monoclonal antibody specifically
precipitated the in vitro-synthesized ORF 3 protein, but no protein from LDV virions. The overall results suggest that the
ORF 3 protein is a nonstructural, highly glycosylated, and antigenic glycoprotein that is probably soluble and secreted or
at most only weakly associated with membranes via the signal peptide. q 1997 Academic Press
Lactate dehydrogenase-elevating virus (LDV) belongs to glycosylated, antigenic glycoprotein that is probably pro-
duced in soluble form.a new family of positive-strand RNA viruses (presently clas-
sified as genus Arterivirus; 1, 2) which also includes equine A cDNA carrying ORF 3 (orf3m) was generated by poly-
merase chain reaction (PCR), using as a template cDNAarteritis virus (EAV), porcine reproductive and respiratory
syndrome virus (PRRSV), and simian hemorrhagic fever 323-4-2 (15, 16; GenBank Accession No. U15146). The
primers were specific for the 5*- and 3*-ends of ORF 3virus (2–4). Their genomic RNAs of 12 to 15 kb are trans-
and also carried BamHI restriction sites at the terminilated into large proteins (1a and 1b) with protease, repli-
(Fig. 1A). After digestion with BamHI, the PCR-generatedcase, helicase, and zinc finger motifs. The other genes are
sequence (586 nucleotides) was cloned into the BamHIexpressed via formation of a 3* coterminal nested set of
restriction site of pCDNAI/Amp (Invitrogen, Inc., San6 subgenomic mRNAs (mRNAs 2–7). Only the 5* open
Diego, CA) with the T7 promoter upstream of the ORF,reading frame (ORF) of each subgenomic mRNA is thought
to yield clone pCDorf3m. pCDorf4m was generated in ato be translated (ORFs 2 to 7). ORF 7 encodes the nucleo-
similar manner using as template a combined cDNA ofcapsid protein (N) and ORF 6, a nonglycosylated envelope
clones 300-1 F-1 and 348-10 (15, 17) that were joined atprotein (M), which is disulfide bonded to the primary enve-
a common StuI site. The generation of similar pCD cloneslope glycoprotein (designated VP-3P, GL , or E) coded for
carrying ORFs 2, 5, 6, and 7 has been described pre-by ORF 5. All neutralizing anti-LDV and anti-EAV antibodies
viously (12).are specific for the ORF 5 protein (5–9). ORFs 2 to 4 encode
For in vitro transcription and translation, plasmid DNAsglycoproteins but their functions are uncertain. The ORF 2
were prepared by the alkaline lysis method, linearizedprotein is a very minor virion protein of EAV (GS ; 10, 11)
with Xhol, extracted first with phenol:chloroform:isoamyland probably of LDV (VP-3M; 12), whereas the ORF 3 and
alcohol (25:24:1) and then with chloroform:isoamyl alco-ORF 4 proteins have been reported to be minor structural
hol (24:1), and agarose gel purified. After ethanol precipi-proteins of the Lelystad strain of PRRSV with molecular
tation, the DNA samples were washed in 70% (v/v) etha-weights of 45–50 and 31–35 kDa, respectively (13, 14). In
nol, dried, and resuspended in water at a concentrationcontrast to the latter results, our present study indicates
of 1 mg/ml. In vitro transcription with T7 polymerase (Newthat the ORF 3 protein of LDV is a nonstructural, highly
England Biolabs, Beverly, MA) was performed as outlined
by Beckler (18) and the transcripts were freed of most of
the template DNA by precipitation in 2.5 M ammonium1 To whom correspondence and reprint requests should be ad-
dressed. acetate (Epicentre Forum, Vol. 1, No. 2, page 8, 1994).
245
0042-6822/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID VY 8310 / 6a26h$$221 12-06-96 03:45:34 vira AP: Virology
246 SHORT COMMUNICATION
To investigate the association of the ORF 3 protein
with microsomal membranes, the translation products
were incubated and centrifuged under different buffer
conditions as described previously (12). In brief, the
translation reaction mixtures (70,000 cpm/sample) were
diluted to 4.5 ml with ice-cold Tris-buffered sucrose (250
mM sucrose, 25 mM Tris–HCl, pH 7.5) or 100 mM sodium
carbonate (pH 11.5) and the mixtures were incubated for
1 hr on ice (20–22). The individual samples were then
centrifuged for 1 hr at about 100,000 g and the pellet (P)
and supernatant (S) were analyzed for the ORF 3 product.
When incubated in isotonic sucrose buffer, the micro-
somal membranes remain closed vesicles and all pro-
teins associated with the membrane and those located
within the vesicles will be located in the membrane pel-
let, whereas proteins synthesized on free ribosomes will
be recovered in the supernatant. In contrast, when the
translation products are incubated in 100 mM Na/-car-
bonate at pH 11.5, the membrane vesicles are disrupted
and only integral membrane proteins remain associated
with the pelleted membranes, whereas secreted glyco-
proteins and peripheral proteins are recovered in the
supernatant (21). After centrifugation of the incubated
reaction mixtures, the proteins remaining in the superna-
tant fraction were precipitated with TCA, washed in ace-
tone, air dried, and resuspended in reducing acrylamide
FIG. 1. 5*- and 3*-ends of ORF 3 of LDV strain P (2, 15, 16) indicating gel sample buffer consisting of 110 mM Tris–HCl, pH
segments (overlined) for which sense and antisense (indicated by
6.8, containing 17% (v/v) glycerol, 5% (w/v) sodium dode-slashes after and before designation, respectively) oligonucleotides
cyl sulfate (SDS), 0.35% (w/v) bromphenol blue, and 8.4%were prepared for PCR amplification, and predicted amino acids en-
coded by the shown nucleotide sequences (A), and hydrophobic mo- (v/v) 2-mercaptoethanol. The pelleted (P) microsomal
ment analyses of the predicted ORF 3 (B) and ORF 4 (C) proteins membranes (and associated proteins) were washed
according to the method of Eisenberg et al. (43). In (A) the hydrophobic once with sterile water and then resuspended in reduc-
segment of the predicted signal peptide sequence is underlined. The
ing sample buffer. The suspensions were heated at 957potential N-glycosylation site in the shown segment is doubly under-
for 10 min and clarified by centrifugation in an Eppendorflined. The locations of all potential N-glycosylation sites are indicated
in (B) and (C) by C. The ORF 3 protein does not possess any 21-amino centrifuge. The supernatant fluids were analyzed by con-
acid long segment with a mean hydrophobicity of 50, except for the ventional SDS–PAGE (23) using 15%T:0.4%C polyacryl-
signal peptide (B). The mean hydrophobicity of the potential C-terminal amide gels [T refers to total percentage of acrylamide
transmembrane segment of the ORF 4 protein (amino acids 155–175)
and bisacrylamide monomers and C to the percentageis 67.6 (C).
of crosslinker relative to T (24)] or tricine SDS–PAGE (25)
using either 16.5%T:3%C or 10%T:3%C polyacrylamide
gels. Molecular weights of in vitro-synthesized productsThe transcripts were dissolved in H2O to approximately
1 mg/ml and their integrity was verified by agarose gel were estimated by comparing their migration to those of
radiolabeled marker proteins purchased from GIBCOelectrophoresis.
The transcribed RNAs were in vitro translated in a BRL (Gaithersburg, MD).
ORF 3 of LDV encodes a 191 amino acid protein (21.5rabbit reticulocyte system as described by the manufac-
turer and previously (12). Fifty-microliter reaction volumes kDa) which possesses six potential N-glycosylation sites
(Fig. 1B). The Eisenberg hydrophobic moment profile (Fig.containing 35 ml of Flexi Rabbit Reticulocyte Lysate (Pro-
mega, Madison, WI), 70 mM KCl, 20 mM amino acid 1B) predicts the presence of an N-terminal signal peptide
sequence, but no transmembrane domain downstreammixture without L-methionine, 0.8 U RNasin/ml, 0.8 mCi L-
[35S]methionine/ml, and 20 ng RNA/ml were incubated for to anchor this protein in the membrane. When ORF 3
was translated without microsomal membranes, most of1 hr at 307 and then analyzed for the amount of [35S]-
methionine (cpm) incorporated into protein by trichloro- the protein produced migrated to about 20–21 kDa (the
predicted size of the ORF 3 protein) and was found in theacetic acid (TCA) precipitation (15%, w/v). Where indi-
cated, 3.6 ml of canine pancreatic microsomal mem- S fraction after incubation and centrifugation in isotonic
sucrose buffer (Fig. 2A, lane 1). When translated in thebranes (Promega) were added per 50 ml of translation
mixture (19). presence of microsomal membranes and incubated and
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FIG. 2. SDS–PAGE analyses of the ORF 3 (A, B) and ORF 4 (C) proteins, which were synthesized in the absence (0) and presence (/) of
pancreatic membranes, and, where indicated, further incubated in the Tris/sucrose, pH 7.5, or carbonate buffer, pH 11.5. The reaction mixtures
were centrifuged at about 100,000 g and the proteins in both the supernatant (S) and pellet (P) fractions were analyzed by SDS–PAGE using 16.5:3%
tricine gels (for further experimental details see text and Ref. 12). Lane 1 in (C) shows the location of marker (M) proteins and lane 2 the profile of
the in vitro-synthesized ORF 4 protein before centrifugation. Significant amounts of protein were not synthesized in the absence of mRNA (data not
shown).
centrifuged under isotonic conditions, the main protein a predicted molecular weight of about 19 kDa, possesses
five potential glycosylation sites, and hydrophobic mo-product of ORF 3 RNA migrated to about 36 kDa, sug-
gesting glycosylation, and was now present in the pel- ment analysis predicted the presence of an N-terminal
signal peptide and a C-terminal membrane anchor (Fig.leted membrane fraction (P; Fig. 2A, lane 4) indicating
membrane association. However, when the reaction mix- 1C). In this case, very little of the protein, predicted to
be about 19 kDa, was synthesized when the ORF 4 RNAture containing the membrane-associated ORF 3 protein
was incubated and centrifuged in sodium carbonate, pH was translated in the absence of membranes (data not
shown). However, in the presence of membranes a major11.5, most of the resulting glycosylated ORF 3 protein
product was now recovered in the S fraction (Fig. 2B, protein of about 31 kDa was synthesized (Fig. 2C, lane
2), which was recovered in the P fraction whether thelane 3). This result suggests that the ORF 3 protein was
released in undegraded form from the membranes upon reaction products were incubated in Tris/sucrose or car-
bonate buffer, pH 11.5 (Fig. 2C, lanes 4 and 6). The resultsdisruption of the vesicles. Thus the ORF 3 protein was
present in free form in the lumen of the vesicles or only are similar to those obtained for the ORF 2 and ORF 5
proteins (12) but contrast with those observed for theperipherally associated with the membranes. This con-
clusion was further supported by the finding that after ORF 3 protein. They indicate that the ORF 4 protein is
firmly anchored in the membrane and is a glycosylated,incubation in the pH 11.5 buffer the glycosylated ORF 3
protein was completely digested by incubation with 0.1 class I (designation of von Heijne, Refs. 28, 29) integral
membrane protein. We have previously observed thatmg proteinase K/ml at pH 7.5 for 1 hr on ice (12), whereas
after incubation in the isotonic sucrose buffer the protein the in vitro synthesis of other LDV integral membrane
proteins, such as M/VP-2, was greatly increased in thewas completely resistant (data not shown). Combined,
the results are in agreement with the hydrophobic mo- presence of membranes (12). The size of the ORF 4 pro-
tein synthesized in the presence of membranes (31 kDa)ment analysis (Fig. 1B) that predicts lack of any trans-
membrane segment besides the potential signal peptide. suggests that all five of its N-glycosylation sites were
core glycosylated.The increase in molecular weight of the ORF 3 protein
upon synthesis in the presence of membranes of about To further assess the structure of the ORF 3 protein
synthesized in the presence of membranes we incubated16 kDa suggests that all of its six N-glycosylation sites
are core glycosylated since the carbohydrate core [(glu- the protein with endoglycosidase F/N-glycosidase
(glyco-F, Boehringer-Mannheim, Indianapolis, IN) in thecose)3-(mannose)9-(N-acetylglucosamine)2] (26) has a
molecular weight of about 2.6 kDa (27). presence of Nonidet P-40 as described previously (12).
This treatment resulted in reducing its size from aboutFor comparative purposes we synthesized the ORF 4
protein in vitro and analyzed it in the same manner as 36 to about 20 kDa (Fig. 3, lanes 3 and 4), consistent
with the removal of its six core oligosaccharides. Thedescribed for the ORF 3 protein. The ORF 4 protein has
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lar enzyme cleaves P62 at residue 65 to form E3 and E2.
E2 along with E1 forms trimers in the envelope of infec-
tious virions, whereas E3 is released into the medium
(31). Like the LDV-ORF 3 protein, the E3 protein lacks N-
terminal positively charged amino acids.
Since the preceding results suggested that the ORF 3
protein is a soluble LDV protein and is probably released
from infected macrophages, we reasoned that it may
induce an antibody response in infected mice and that
some of our anti-LDV monoclonal antibodies (mAbs) iso-
lated in previous studies (5, 32) may be ORF 3 protein-
specific. We therefore tested plasma from 2-month LDV-
infected mice (IMP) for precipitation of the in vitro-synthe-
sized ORF 3 protein and similarly screened the previously
FIG. 3. Glyco-F treatment of in vitro-synthesized ORF 3 protein. The generated batteries of anti-LDV mAbs. To assess speci-
protein was synthesized in absence (0) and presence (/) of pancreatic
ficity of the antibodies we also determined the immuno-membranes. Portions of products were incubated with (/) and without
precipitation of in vitro-synthesized ORF 2, 4, 5, 6, and 7(0) glyco-F and then analyzed by SDS–PAGE using a 16.5:3% tricine
gel. proteins. The availability of these in vitro-synthesized
LDV proteins made it possible for the first time to fully
assess the specificity of various available anti-LDV poly-
remaining protein comigrated with the ORF 3 protein syn- clonal and monoclonal antibodies. Mixtures of the ORF
thesized in the absence of membranes under several 3 and 4 proteins and of the ORF 2, 5, 6, and 7 proteins
different electrophoretic conditions (Fig. 3, lanes 1, 2, and were incubated with various antibody preparations and
4; data not shown). This finding was unexpected since the precipitated proteins analyzed by SDS–PAGE. In
the ‘‘-3 -1 rule’’ of von Heijne (28, 29) predicts the pres- agreement with results from previous immunoblot analy-
ence of typical signal peptidase cleavage sites in the ses, the main antibody response of infected mice is to
ORF 3 protein just downstream of the hydrophobic seg- VP-3P (5–7, 12); IMP strongly immunoprecipitated the
ment of the signal peptide (-1 A26, -3 V24 or -1 S27, -3 T25; ORF 5 protein (Fig. 4B, lane 3). Some precipitation of the
Fig. 1A). Cleavage at one of these sites should have ORF 7 protein (N/VP-1) was observed, but little, if any,
resulted in a deglycosylated product with a molecular precipitation of the ORF 2 or ORF 6 proteins (Fig. 4B,
weight about 2.1 kDa lower than that of the basic protein. lane 3) or of the ORF 4 protein (Fig. 4A, lane 4). In contrast,
One explanation for this discrepancy might be that, al- the ORF 3 protein was efficiently precipitated by IMP
though the signal peptide was cleaved, other posttransla- (Fig. 4A, lane 4, and data not shown), indicating that the
tional alterations or changes in protein structure lowered IMP contained antibodies that strongly reacted with this
the mobility of the deglycosylated product. A more likely protein. The reaction was specific; no precipitation of
explanation, however, is that the signal peptide of the any of the LDV proteins by normal mouse plasma was
ORF 3 protein remains uncleaved, most likely because observed (Fig. 4A, lane 3, and Fig. 4B, lane 2).
the rapid glycosylation of N23 close to the putative signal All anti-LDV mAbs characterized to-date have been
peptidase cleavage sites (Fig. 1A) prevents this cleavage. shown by immunoblotting to be specific for VP-3P (en-
Glycosylation of the signal peptide may also have pre- coded by ORF 5) with the exception of one mAb
vented its reinsertion into the membrane to form a class (C350201.7) that was generated to isolated nucleocap-
II integral membrane protein (designation of von Heijne, sids and is specific for the N-protein (5, 7, 8, 12, 32, 33).
28, 29). The absence in the ORF 3 protein of any N- The anti-VP-3P mAbs specifically precipitated the in vitro-
terminal-positive charged amino acids, which seem to synthesized ORF 5 protein (12; see lane 4, Fig. 4B). In
play a role in determining the topography of integral the present study, we found that one previously gener-
membrane proteins (28, 29), may contribute to retention ated, but uncharacterized mAb (F2) specifically immuno-
of the ORF 3 protein in soluble form. A precedent support- precipitated the ORF 3 protein (Fig. 4A, lane 6) and an-
ing this hypothesis is the E3 protein of Sindbis virus other (E3) the ORF 7 protein (N; Fig. 4B, lane 6). Both of
(30). E3 is synthesized as part of a large glycoprotein these mAbs were produced by hybridomas that were
precursor consisting of P62 (pE2, the precursor for E3 generated with spleen cells from LDV-P-infected mice
and E2), 6K, and E1. Signal peptidase catalyzes the cleav- (32, and Chan, Harty, and Plagemann, unpublished data).
age between the three proteins but the removal of the The availability of a mAb to the ORF 3 glycoprotein
N-terminal signal peptide of P62 is blocked by rapid gly- made it possible to assess whether the ORF 3 protein
cosylation of N14 (30). P62, 6K, and E1, each anchored is associated with virions, perhaps at a low level, just
in the membrane, move together through the secretory as VP-3M. For this purpose, LDV-infected macrophage
cultures were incubated with [35S]methionine overnightpathway to the plasma membrane, where another cellu-
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FIG. 4. Immunoprecipitation of in vitro-synthesized ORF 2 to 7 proteins by normal mouse plasma (NMP), plasma from 2-month LDV-P-infected
mice (IMP) (6), anti-LDV mAb B6506A7 (6A7; IgG2a; kindly provided by Dr. J.-P. Coutelier; 8) or mAbs F2 (IgG1), or E2 (IgG2a; 32). The proteins were
synthesized in the presence of pancreatic membranes. In (A), the ORF 3 and 4 proteins were mixed, and in (B) the ORF 2 and ORF 5–7 proteins
were mixed. The proteins were incubated with the indicated antibody preparations under nonreducing conditions, then with protein G–Sepharose
in RIPA buffer, and the precipitates were then washed in HEPES lysis buffer and analyzed by SDS–PAGE as described previously using 10:3%
tricine gels (12, 33).
and LDV virions were isolated from the culture fluid as and nonspecifically some N protein (12); mAb E3 specifi-
cally precipitated the N protein (Fig. 5, lane 6). However,described previously (12). Since VP-3P constitutes mole-
cules with a wide range of molecular weights due to no glycoprotein with an expected molecular weight of
⁄31 kDa was precipitated by the ORF 3-specific mAb F2different sizes of the oligosaccharide chains (about 25
to 40 kDa; Fig. 5, lane 1) the broad protein band could (Fig. 5, lane 5). The results indicate that the ORF 3 protein
is not associated to a significant extent with LDV virionsencompass other virion glycoproteins, as seems to be
the case for the minor envelope glycoprotein VP-3M (12). and thus a nonstructural glycoprotein.
We have attempted to determine the fate of the ORFHowever, the VP-3P proteins were immunoprecipitated
in a similar pattern by IMP and the anti-VP-3P mAb 6A7 3 protein in infected cells, but unsuccessfully. Northern
blot hybridization has shown that the ORF 3 mRNA is(Fig. 5, lanes 3 and 4). mAb 6A7 also precipitated the M
protein since the latter is disulfide bonded to VP-3P (33), synthesized in LDV-infected primary macrophage cul-
tures in amounts similar to those of the other subgenomic
mRNAs (15, 17), but we have been unable to detect the
ORF 3 protein in infected macrophage cultures. VP-3P
and N/VP-1 are readily detected in infected macrophages
by indirect fluorescent antibody (IFA) staining using spe-
cific mAbs (2–6) but no significant IFA staining was ob-
served with the ORF 3 protein-specific mAb F2 (data not
shown). Either the ORF 3 protein is synthesized only in
low amounts or rapidly secreted by the cells (15–17).
We have also not been able to immunoprecipitate the
ORF 3 protein from the medium or from extracts of in-
fected macrophages that had been incubated with [35S]-
methionine from 4 to 12 hr p.i. (data not shown), but this
negative result was not surprising since we have also
been unable to immunoprecipitate VP-3P and N from
extracts of such radiolabeled infected cultured macro-
phages, though radiolabeled virions can be isolated fromFIG. 5. Immunoprecipitation of LDV virion proteins by NMP, IMP,
and mAbs 6A7, F2, and E3. LDV virion proteins were radiolabeled by the culture fluid (6, 12; see Fig. 5). It seems the concentra-
propagation of LDV-P in primary cultures of mouse peritoneal macro- tion of the virion proteins in infected macrophages are
phages in the presence of [35S]methionine as described previously
very low relative to the amounts of cellular proteins, be-(12, 33). The virions were lysed and the proteins in the lysate were
cause only a small proportion of macrophages in primaryimmunoprecipitated under nonreducing conditions in the same manner
as the in vitro-synthesized ORF 2 to 7 proteins using RIPA buffer. cultures supports LDV replication (2–4).
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TABLE 1
Comparison of Properties and Amino Acid Homologies of Arterivirus ORF 3 Proteinsa
Amino acid identity (%)c
Virus AAb kDa GSb LDV-C PRRSV-LV PRRSV-VR2332 EAV
LDV-P 191 21.5 6(N23) 88.0 38.7 40.3 26.4
LDV-C 191 21.6 6(N23) — 37.1 38.2 25.2
PRRSV-LV 265 30.6 7(N27) — — 60.6 36.8
PRRSV-VR2332d 254 29.0 7(N29) — — — 38.7
EAV 163 18.1 6(N28) — — — —
a Sequences for LDV-C, PRRSV (strains LV and VR2332), and EAV (Bucyrus strain) have been reported by Godeny et al. (36); Meulenberg et al. (37);
Murtaugh et al. (38), and den Boon et al. (39), respectively (GenBank Accession Nos. L13298, M96262, L04493, and X53459, respectively).
b AA, total amino acids encoded by ORF 3; GS, number of potential N-glycosylation sites (the most N-terminal GS is indicated in parenthesis).
c Amino acid identities were determined by the algorithm of Needleman and Wunsch (40) to align sequences and to divide the number of identical
residues by the total number of amino acids of the smaller of the indicated sequences.
d The ORF 3 proteins of two other North American isolates of PRRSV, VR2385 (41), and IAF-exp91 (42) have the same number of amino acids and
exhibit 93 and 94% amino acid identity, respectively.
Unfortunately no LDV-permissive cell line is available Further work is required to explore whether the N-termi-
nal-positive charge is associated with binding of some(2–4). We have also transiently expressed clones
pCDorfs 2 to 5 in COS-1 cells. All mRNAs were synthe- ORF 3 protein to the other envelope proteins and ac-
counts for the retention of the ORF 3 protein in PRRSV-sized in the transfected cells as indicated by results from
Northern hybridization analyses, but attempts to immuno- LV virions and to determine the fate of the ORF 3 protein
in LDV-infected macrophages.precipitate the protein products with IMP or the specific
mAbs were unsuccessful and no ORF 3 protein was de-
tected by IFA staining with mAb F2 (data not shown). ACKNOWLEDGMENTS
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